Richard Faragher

3.8k total citations
87 papers, 2.8k citations indexed

About

Richard Faragher is a scholar working on Physiology, Molecular Biology and Aging. According to data from OpenAlex, Richard Faragher has authored 87 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Physiology, 41 papers in Molecular Biology and 28 papers in Aging. Recurrent topics in Richard Faragher's work include Telomeres, Telomerase, and Senescence (40 papers), Genetics, Aging, and Longevity in Model Organisms (28 papers) and DNA Repair Mechanisms (17 papers). Richard Faragher is often cited by papers focused on Telomeres, Telomerase, and Senescence (40 papers), Genetics, Aging, and Longevity in Model Organisms (28 papers) and DNA Repair Mechanisms (17 papers). Richard Faragher collaborates with scholars based in United Kingdom, United States and Germany. Richard Faragher's co-authors include David Kipling, Dominick G. A. Burton, Elizabeth L. Ostler, Andrew W. Lloyd, S. P. Denyer, Terence Davis, Corrin Wallis, Ian R. Kill, Christopher J. Jones and Angela N. Sheerin and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Richard Faragher

84 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard Faragher United Kingdom 27 1.3k 1.1k 425 265 222 87 2.8k
Song Eun Lee South Korea 17 895 0.7× 438 0.4× 85 0.2× 158 0.6× 351 1.6× 103 2.5k
Jing Ye China 28 1.1k 0.8× 616 0.5× 135 0.3× 108 0.4× 121 0.5× 143 2.4k
Khalid Al-Regaiey Saudi Arabia 24 1.1k 0.8× 1.6k 1.4× 657 1.5× 43 0.2× 245 1.1× 60 2.9k
Amelia Morrone Italy 29 1.6k 1.2× 1.7k 1.5× 95 0.2× 60 0.2× 255 1.1× 145 3.4k
Cheng Li China 26 941 0.7× 298 0.3× 56 0.1× 354 1.3× 138 0.6× 106 2.6k
Woei‐Cherng Shyu Taiwan 38 2.4k 1.9× 447 0.4× 90 0.2× 126 0.5× 644 2.9× 148 5.8k
Mark Berneburg Germany 38 1.8k 1.4× 287 0.3× 68 0.2× 233 0.9× 636 2.9× 178 5.0k
Brian J. Feldman United States 26 2.2k 1.7× 741 0.7× 69 0.2× 169 0.6× 280 1.3× 46 5.2k
Yi‐Fan Chen Taiwan 28 1.2k 0.9× 244 0.2× 95 0.2× 55 0.2× 111 0.5× 104 2.2k
Lizzia Raffaghello Italy 42 2.5k 1.9× 968 0.9× 122 0.3× 138 0.5× 1.4k 6.4× 101 6.3k

Countries citing papers authored by Richard Faragher

Since Specialization
Citations

This map shows the geographic impact of Richard Faragher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Faragher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Faragher more than expected).

Fields of papers citing papers by Richard Faragher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Faragher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Faragher. The network helps show where Richard Faragher may publish in the future.

Co-authorship network of co-authors of Richard Faragher

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Faragher. A scholar is included among the top collaborators of Richard Faragher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Faragher. Richard Faragher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Faragher, Richard, et al.. (2024). A SIRT1-independent mechanism mediates protection against steroid-induced senescence by resveralogues in equine tenocytes. PLoS ONE. 19(8). e0309301–e0309301. 1 indexed citations
2.
Tamura, Norihisa, N. Heidari, Richard Faragher, Roger K. Smith, & Jayesh Dudhia. (2023). Effects of resveratrol and its analogues on the cell cycle of equine mesenchymal stem/stromal cells. Journal of Equine Science. 34(3). 67–72. 1 indexed citations
3.
Cox, Lynne S. & Richard Faragher. (2022). Linking interdisciplinary and multiscale approaches to improve healthspan—a new UK model for collaborative research networks in ageing biology and clinical translation. The Lancet Healthy Longevity. 3(5). e318–e320. 7 indexed citations
4.
Faragher, Richard & Elizabeth L. Ostler. (2020). Resveralogues: From Novel Ageing Mechanisms to New Therapies?. Gerontology. 66(3). 231–237. 2 indexed citations
5.
Sheerin, Angela N., et al.. (2020). Novel resveratrol derivatives have diverse effects on the survival, proliferation and senescence of primary human fibroblasts. Biogerontology. 21(6). 817–826. 13 indexed citations
6.
Overall, Andrew & Richard Faragher. (2019). Population type influences the rate of ageing. Heredity. 123(2). 273–282. 3 indexed citations
8.
Burton, Dominick G. A. & Richard Faragher. (2018). Obesity and type-2 diabetes as inducers of premature cellular senescence and ageing. Biogerontology. 19(6). 447–459. 133 indexed citations
9.
Ibrahim, Badr, et al.. (2016). Absence of premature senescence in Werner's syndrome keratinocytes. Experimental Gerontology. 83. 139–147. 9 indexed citations
10.
Faragher, Richard. (2015). Should we treat aging as a disease? The consequences and dangers of miscategorisation. Frontiers in Genetics. 6. 171–171. 25 indexed citations
11.
Burton, Dominick G. A. & Richard Faragher. (2015). Cellular senescence: from growth arrest to immunogenic conversion. AGE. 37(2). 27–27. 71 indexed citations
12.
Burton, Dominick G. A., Angela N. Sheerin, Elizabeth L. Ostler, et al.. (2007). Cyclin D1 Overexpression Permits the Reproducible Detection of Senescent Human Vascular Smooth Muscle Cells. Annals of the New York Academy of Sciences. 1119(1). 20–31. 40 indexed citations
13.
Lowe, Jillian E., Seema Shah, Richard Faragher, et al.. (2006). α-Lipoic acid and glutathione protect against the prooxidant activity of SOD/catalase mimetic manganese salen derivatives. Journal of Inorganic Biochemistry. 101(2). 225–232. 19 indexed citations
14.
Parry, Elizabeth M., et al.. (2005). Molecular cytogenetic insights into the ageing syndrome Hutchinson-Gilford Progeria (HGPS). Cytogenetic and Genome Research. 111(1). 27–33. 14 indexed citations
15.
Lowe, J., Angela N. Sheerin, Dominick G. A. Burton, et al.. (2004). Camptothecin Sensitivity in Werner Syndrome Fibroblasts as Assessed by the COMET Technique. Annals of the New York Academy of Sciences. 1019(1). 256–259. 11 indexed citations
16.
Davis, Terence, Richard Faragher, Christopher J. Jones, & David Kipling. (2004). Investigation of the Signaling Pathways Involved in the Proliferative Life Span Barriers in Werner Syndrome Fibroblasts. Annals of the New York Academy of Sciences. 1019(1). 274–277. 8 indexed citations
17.
Davis, Terence, Julia W. Skinner, Richard Faragher, Christopher J. Jones, & David Kipling. (2004). Replicative senescence in sheep fibroblasts is a p53 dependent process. Experimental Gerontology. 40(1-2). 17–26. 26 indexed citations
18.
Yeoman, Mark S. & Richard Faragher. (2001). Ageing and the nervous system: insights from studies on invertebrates. Biogerontology. 2(2). 85–97. 21 indexed citations
19.
Faragher, Richard & David Kipling. (1999). How might replicative senescence contribute to human ageing?. BioEssays. 20(12). 985–991. 109 indexed citations
20.
Faragher, Richard, B. Mulholland, Stephen J. Tuft, Susan Sandeman, & Peng T. Khaw. (1997). Aging and the cornea. British Journal of Ophthalmology. 81(10). 814–817. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026